Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

August 01, 2011 (Vol. 31, No. 14)

Solutions for Easing Antibody Processing

Researchers Incorporate Innovative Technologies into Processes to Address Purification Challenges

  • New drug approvals in the U.S. and EU continue in the range of 20 to 25 per year, with vaccines and monoclonal antibodies accounting for the lion's share. While this rate is lower than what was anticipated, the ongoing development and introduction of new antibody-based pharmaceuticals is putting pressure ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.